Pitavastatin attenuates cisplatin-induced renal injury by targeting MAPK and apoptotic pathways.
Swati KaushikAmeesha TomarSusrutha Puthanmadhom NarayananTapas Chandra NagDharamvir Singh AryaJagriti BhatiaPublished in: The Journal of pharmacy and pharmacology (2019)
Cisplatin-induced acute renal injury was improved on administration of pitavastatin via inhibition of MAPK and apoptotic pathway.